NovaGen Group advances longevity science through cellular research, AI health intelligence, and partner-network education.
Our Mission
From Lab Discovery to Global Access—The NovaGen Group Story
Building partner relationships and educational resources with local governance in mind.
Supporting careful longevity research, transparent education, and physician-led discussion.
The principles that guide our mission to make longevity accessible to all
A future shaped by responsible longevity science
To advance cellular research and education responsibly
Clear communication and responsible boundaries
Careful with claims and evidence
Responsible oversight and review
Continuously advancing the science
Working to democratize longevity
Open about our methods and results
Whether you're a patient, healthcare provider, researcher, or investor, we invite you to be part of the longevity revolution.
Our Team
Led by experienced executives and guided by distinguished advisors
Operators, scientists, and builders coordinating NovaGen Group's research-led platform.
8 leaders
Diederik van der Reijt is the CEO and Co-founder. A serial biotech entrepreneur and investor, he previously built a successful high-frequency trading firm and co-founded NKore Biotherapeutics, and now leverages his finance and venture capital background to democratize access to breakthrough cellular therapies.
Chief Scientific Officer
Professor, UCLA Department of Molecular & Medical Pharmacology. Pioneer in neural stem cell biology and leading expert in cellular reprogramming. Academic excellence with breakthrough discoveries in JAK-STAT pathways and successful translation from bench to bedside.
Co-founded and led more than 20 life sciences companies, including Drug Discovery Factory, Skyline Diagnostics, Julius Clinical, DC4U, MyLife Technologies, and Oncodrone. Physician, scientist, and serial biotech entrepreneur with expertise in clinical immunology, transfusion medicine, and genetics.
Chief Development Officer
Seasoned business professional with a strong track record in commercializing innovative healthcare technologies in China. Proven leader in scaling ventures, securing strategic partnerships, and driving global market expansion.
He is a member of the OECD's AI Expert Group and CEO of Erasmus.AI, a platform creating domain-specific AI models like ClimateGPT, the world's first foundational Climate Change model. With 25 years of experience in strategy and foresight advisory, he is also a full member of the Club of Rome.
Scientific and clinical advisors supporting research context and review.
6 members
Member of the European Board of Plastic Surgeons (EBOPRAS), specializes in Plastic, Reconstructive, and Aesthetic Surgery. President of the French Society of Aesthetic Plastic Surgery (SOFCEP) and member of IPRAS and ESPRAS.
Cardiologist & Anti Aging Physician
Cardiologist, morphologist, and anti-aging physician with training in nutritional and functional medicine with Professor Vincent Castronovo. President of AEM2F, the European Association of Mitronutrition and Functional Medicine.
Clinical Director, UCLA
Clinical Director for preclinical research, focusing on Auto-rFib therapy research with expertise in cell culture and animal experiments. Leads preclinical investigations for neurodegenerative disease applications.
Biomedical engineer and translational scientist focused on turning frontier longevity and regenerative medicine research into deployable therapies. Leads NovaGen Group's innovation pipeline, bridging AI-driven discovery, clinical partners, and global research networks.
Founder and Medical Director of Body & Soul in Shanghai. With over 20 years' experience in Traditional Chinese and Western Medicine, specializes in women's health, fertility, and pediatrics, delivering care in four languages.
Prof. Dr. Murat Bozkurt is a Turkish orthopedic surgeon specializing in joint surgery, arthroscopy, arthroplasty, and sports medicine. He combines extensive clinical practice in Ankara with academic, research, and international teaching activities in musculoskeletal and regenerative medicine.
Global advisors across finance, partnerships, governance, and cross-border strategy.
7 members
International business development executive with extensive experience in Asia-Pacific markets and cross-border partnerships. Specializes in strategic planning and market expansion for biotechnology companies, with deep expertise in regulatory affairs and commercial strategy.
Global business leader with 40+ years experience specializing in cross-border investments in Asia and the Middle East. Founder of the George H. W. Bush Foundation for U.S.-China Relations. Chairs Points of Light and the Bush School Advisory Board.
Senior executive and strategic advisor with extensive experience in finance, biotechnology, and investor advocacy. Recognized for leadership roles at major asset management firms and commitment to advancing women's representation in finance. Active philanthropist supporting education, science, and ocean preservation.
Non-Executive Director
Former British Consul-General to Hong Kong, graduated from Oxford in 1980 and studied at Fudan University. Leverages extensive diplomatic experience across Asia to advise on cross-border consultancy and strategic development. Serves on the boards of Cenovus Energy Inc., CK Asset Holdings, and Power Assets Holdings.
Co-founder and Managing Partner of GCW Global Customised Wealth, specializing in private equity and family office investments. Previously held senior positions at Jasper Ridge Partners, Nomura, and Lehman Brothers. Has served as an economic advisor to two U.S. Presidents. Ph.D. in Economics from Stanford University.
Co-Founder and Chairman of MCM Partners, a Hong Kong-based merchant bank and corporate advisory firm. Accomplished finance executive with extensive leadership in global equities and derivatives, previously serving as Head of Global Equities at Nomura and Head of European Equities at Lehman Brothers.
Shirin Azad is Strategic Advisor for Europe where she supports the company’s mission to advance investigational cellular longevity technologies. Based in London, she is an ex-headhunter, investor, and philanthropist with international experience across the UK and Germany, and she brings a strong interest in health, longevity, and patient advocacy to her work.
Important Medical Notice: Content on this website is educational and informational only. NovaGen Group does not provide medical advice, diagnosis, or treatment through this website. Any investigational protocol information should be discussed with qualified, licensed healthcare professionals. Availability and regulatory status vary by jurisdiction.